Concepedia

M. Charokopou

MC

10

Publications

270

Citations

10

H-Index

2015

Active since

Affiliations

UCB Pharma (Belgium)(Current)

Pharmerit (Netherlands)

AstraZeneca (United Kingdom)

AstraZeneca (Sweden)

Bristol-Myers Squibb (France)

M. Charokopou is an author at UCB Pharma (Belgium) specializing in health policy, public health, and orthopaedics.

Top concepts

Publications per year

2015–2021

10

Publications

10

Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older

Emma Söreskog, O. Ström, Anna Spångéus et al. · Bone · 2020 · 71 citations · Full text

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

M. Charokopou, Phil McEwan, Steven Lister et al. · BMC Health Services Research · 2015 · 40 citations · Full text

The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus

M. Charokopou, Phil McEwan, Steven Lister et al. · Diabetic Medicine · 2015 · 35 citations

Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013

M. Charokopou, István Májer, Johan de Raad et al. · Value in Health · 2015 · 34 citations · Full text

, , +8

A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs

Edward Atkinson-Clark, M. Charokopou, Nancy Van Osselaer et al. · Epilepsy & Behavior · 2017 · 20 citations · Full text

Rows per page

1–5 of 10